7754.TWO AnnJi Pharmaceutical Co., Ltd.

Healthcare Biotechnology Taiwan OTC Exchange
60.30 TWD
Close of Nov 6, 2026
44.00 86.00
Market cap
TWD 6.94B
P/E
-
P/B
16.82x
ROE
-111.9%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2025.

Is 7754.TWO undervalued?

Graham number

The Graham number of AnnJi Pharmaceutical Co., Ltd. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

AnnJi Pharmaceutical Co., Ltd. fundamental analysis

No fundamental analysis for AnnJi Pharmaceutical Co., Ltd. yet.

AnnJi Pharmaceutical Co., Ltd. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About AnnJi Pharmaceutical Co., Ltd.

AnnJi Pharmaceutical Co., Ltd. develops drugs in the therapeutic areas of neurology, dermatology, and inflammatory disorders. It develops therapeutics, such as AJ201 for the treatment of spinal and bulbar muscular atrophy; AJ302, a histone deacetylase 6 inhibitor for the prevention and treatment of chemotherapy-induced peripheral neuropathy; and AJ303, an anti-fibrotic and anti-inflammatory compound for the treatment of idiopathic pulmonary fibrosis. AnnJi Pharmaceutical Co.…

Full company profile